Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Multiple sclerosis – A riddle of the blood-brain barrier solved

09.04.2015

The creation and progression of multiple sclerosis present scientists with many riddles. Now researchers from the universities of Würzburg and Amsterdam have succeeded in resolving an apparent contradiction in the findings to date. Their work will contribute to a better understanding of the impact of treatments at the so-called blood-brain barrier.

Over two million people worldwide suffer from multiple sclerosis (MS), an initially usually relapsing chronic inflammatory autoimmune disease of the brain and spinal cord. A key element of the progression of the disease is the disruption of the so-called blood-brain barrier. The main component of this barrier are highly specialized cells that line the vascular walls from inside like wallpaper – these are known as endothelial cells. Using surface molecules and transmitters, they control the exodus of immune cells from the bloodstream to the brain tissue with great precision. During an acute flare-up with multiple sclerosis, the endothelial cells increasingly produce different signal molecules, which results in a mass exodus of immune cells to the brain tissue and leads to the characteristic damage.

Two molecules of central significance

Two molecules play important roles in the communication between endothelial and immune cells: The vascular cell adhesion molecule 1, or VCAM-1 for short, sits on the surface of the endothelial cells and serves as a docking point for the receptor of the immune cells, integrin alpha 4 beta 1. Both therefore make good targets for potential drugs. And, in fact, using medicines to block the integrin on the immune cells prevents these from continuing to migrate from the blood to the brain tissue. This is the main action mechanism of the highly effective MS drug Natalizumab.

However, the scientists have been puzzled by a series of contradictory findings that are known in connection with a special variant of VCAM-1. “This molecule can become detached from the cell’s surface under inflammatory conditions and can then be identified in a soluble form in blood,” explains private lecturer Dr. Mathias Buttmann. And in this form it has caused confusion to date.

An irresolvable contradiction

“On the one hand, some studies show that a high concentration of these dissolved molecules in the blood correlates with a high level of inflammatory activity at the blood-brain barrier,” says Buttmann. This suggests that the molecule itself might even disrupt the barrier function. On the other hand, studies on MS patients treated with an interferon beta medicine found precisely the opposite: The higher the concentrations were here, the more reduced the disease activity exhibited by the patients. “Until now, these findings have represented an irresolvable contradiction, and the possible function of the dissolved molecules at the blood-brain barrier has remained unclear,” says Buttmann.

Mathias Buttmann is a senior physician at the University of Würzburg’s Department of Neurology and head of the Neuroimmunological Outpatient Clinic there. Together with scientists from the University of Amsterdam he has now found a solution to the seeming contradiction. The scientists present their work in the current issue of the scientific journal Acta Neuropathologica.

The key results of the study

“We were able to show that not only immune cells but also the endothelial cells of the blood-brain barrier carry integrin alpha 4 beta 1 on their surface,” is how Buttmann summarizes the key finding of this work. And under inflammatory conditions the brain endothelial cells produced more of the molecule. If the endothelial cells were stimulated with the dissolved variant of VCAM-1, they developed a disturbance to their barrier function. If, however, they had been pre-treated with Natalizumab, the barrier function remained largely intact. “This meant we were able to prove that the dissolved VCAM-1 variant disrupts the barrier function of human brain endothelial cells via integrin alpha 4,” explains Dr. Axel Haarmann, member of Buttmann’s team and lead author of the now published study.

Deeper understanding of the mode of action of MS therapeutics

According to the scientists, these findings indicate that Natalizumab has a two-fold protective effect at the blood-brain barrier: Alongside the known immune cell blockade, it also likely acts in a directly protective manner on brain endothelial cells in that it prevents destabilization of the barrier function, which is probably what happens in untreated MS patients.

And what explanation can there be for the fact that in MS patients treated with interferon beta high levels of dissolved VCAM-1 go hand-in-hand with reduced disease activity? Mathias Buttmann has one ready: “It probably makes a difference whereabouts in the body the dissolved molecules are released.” If, as is the case in MS episodes, this happens in inflammatory areas of the brain, the disruption to the blood-brain barrier is intensified. “Under treatment with interferon beta, however, the molecules are probably mainly released close to the injection sites frequently altered by inflammatory activity,” says Buttmann. There they might block integrin receptors on immune cells and in so doing ultimately have a protective effect, only reaching the blood-brain barrier in a small concentration and therefore having no harmful effect there.

Haarmann A, Nowak E, Deiß A, van der Pol S, Monoranu C, Kooij G, Müller N, van der Valk P, Stoll G, de Vries HE, Berberich-Siebelt F, Buttmann M. Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin alpha-4-transduced outside-in signalling. Acta Neuropathologica, published online on March 27, 2015. DOI: 10.1007/s00401-015-1417-0

Contact

Dr. med. Mathias Buttmann, T: +49 (0)931 201-23777, e-mail: m.buttmann@ukw.de

Weitere Informationen:

http://link.springer.com/article/10.1007%2Fs00401-015-1417-0#

Gunnar Bartsch | idw - Informationsdienst Wissenschaft
Further information:
http://www.uni-wuerzburg.de

More articles from Health and Medicine:

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

nachricht Better equipped in the fight against lung cancer
16.05.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

Im Focus: Entangled atoms shine in unison

A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.

The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Designer cells: artificial enzyme can activate a gene switch

22.05.2018 | Life Sciences

PR of MCC: Carbon removal from atmosphere unavoidable for 1.5 degree target

22.05.2018 | Earth Sciences

Achema 2018: New camera system monitors distillation and helps save energy

22.05.2018 | Trade Fair News

VideoLinks
Science & Research
Overview of more VideoLinks >>>